Literature DB >> 6837274

Electron-microscopic visualization of binding of antibodies from sera of glioma patients on cultured glioma cells.

G M Lauro, C Solheid, L Medolago-Albani, N Di Lorenzo, B Guidetti.   

Abstract

Several human cell lines (normal and neoplastic glia, cerebral metastases from adenocarcinoma, fibroblasts) were incubated with sera from patients with well and poorly differentiated glioma and with sera from healthy donors and then stained with PAP complex to define and localize the antibody reaction with cell surface antigens by means of electron microscopy. The sera of glioma patients proved to contain antibodies which bound the tumor-associated antigenic determinants on the cell membranes of gliomas and of cerebral metastases from adenocarcinoma in tissue cultures. Further, absorption testing of the reactive sera on normal brain, well-differentiated astrocytoma and cultured glioblastoma cells, together with cross-reactivity experiments suggests that at least two antigens or groups of antigens are expressed on the glioma cell surface: one shared by well and poorly differentiated glioma cells and the other by poorly differentiated glioma cells and the cells of cerebral metastases from adenocarcinoma.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6837274     DOI: 10.1007/bf00691598

Source DB:  PubMed          Journal:  Acta Neuropathol        ISSN: 0001-6322            Impact factor:   17.088


  27 in total

1.  Improved assay for cytotoxic antiglioma antibody.

Authors:  E A Quindlen; F C Dohan; P L Kornblith
Journal:  Surg Forum       Date:  1974

2.  Tumour-associated surface antigen(s) in human astrocytomas.

Authors:  H B Coakham; M S Lakshmi
Journal:  Oncology       Date:  1975       Impact factor: 2.935

3.  Evaluation of the humoral response of meningioma patients to possible common tumour-associated antigens.

Authors:  S Mottet; A Martin-Achard; N de Tribolet; A C Diserens
Journal:  Acta Neurochir (Wien)       Date:  1980       Impact factor: 2.216

4.  Mechanisms of uptake and the fate of serum proteins and horseradish peroxidase in cultured human glioma cells. A light- and electron-immunocytochemical study.

Authors:  G D Caine; R O Weller; B E Davis; S Cox
Journal:  Acta Neuropathol       Date:  1980       Impact factor: 17.088

5.  Immunobiology of primary intracranial tumors. Part 1: studies of the cellular and humoral general immune competence of brain-tumor patients.

Authors:  M S Mahaley; W H Brooks; T L Roszman; D D Bigner; L Dudka; S Richardson
Journal:  J Neurosurg       Date:  1977-04       Impact factor: 5.115

6.  Common antigenic determinants on human melanoma, glioma, neuroblastoma, and sarcoma cells defined with monoclonal antibodies.

Authors:  R C Seeger; H M Rosenblatt; K Imai; S Ferrone
Journal:  Cancer Res       Date:  1981-07       Impact factor: 12.701

7.  Two separate membrane-bound antigens on human glioma cells in tissue culture detected with sera from glioma patients by immunofluorescence.

Authors:  C Solheid; G Lauro; G Palladini
Journal:  J Neurol Sci       Date:  1976-11       Impact factor: 3.181

8.  Cell-type-specific markers for distinguishing and studying neurons and the major classes of glial cells in culture.

Authors:  M C Raff; K L Fields; S I Hakomori; R Mirsky; R M Pruss; J Winter
Journal:  Brain Res       Date:  1979-10-05       Impact factor: 3.252

9.  The utilization of native glioma antigens in the assessment of cellular and humoral immune responses in malignant glioma patients.

Authors:  M L Apuzzo; K M Sheikh; M H Weiss; J S Heiden; T Kurze
Journal:  Acta Neurochir (Wien)       Date:  1981       Impact factor: 2.216

10.  The morphologic response of cell lines derived from human gliomas to dibutyryl adenosine 3':5'-cyclic monophosphate.

Authors:  D E Bullard; S H Bigner; D D Bigner
Journal:  J Neuropathol Exp Neurol       Date:  1981-05       Impact factor: 3.685

View more
  1 in total

1.  Prostaglandin E2 as an immunomodulating factor released in vitro by human glioma cells.

Authors:  G M Lauro; N Di Lorenzo; M Grossi; A Maleci; B Guidetti
Journal:  Acta Neuropathol       Date:  1986       Impact factor: 17.088

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.